Showing results (1-10 of 47) with videos related to
Sort By:
Pageof 5
Mediterranean Journal of Hematology and Infectious Diseases|March 16, 2016
Anemia in the Elderly: not Always what it SeemsMarco Cerrano, Elena Crisà, Valentina Giai, et al.Haematologica|May 12, 2004
Differentiating agents + low-dose chemotherapy in the management of old/poor prognosis patients with acute myeloid leukemia or myelodysplastic syndromeDario Ferrero, Elisabetta Campa, Chiara Dellacasa, et al.American Journal of Hematology|June 13, 2013
Excellent therapeutic results achieved in chronic myeloid leukemia patients with front-line imatinib and early treatment modifications in suboptimal responders: a retrospective study on 91 unselected patientsMarco Cerrano, Elena Crisà, Patrizia Pregno, et al.Journal of Biotechnology and Biomedicine|January 16, 2023
Hematopoietic Stem Cells (HSC) and Granulocyte Macrophage Progenitors (GMP) are the Oxidative Stress Targets in Low/Intermediate-1 Risk Myelodysplastic SyndromesValentina Giai, Thea Bensi, Claudia Bertassello, et al.British Journal of Haematology|May 11, 2012
Long-term follow-up of myelodysplastic syndrome patients with moderate/severe anaemia receiving human recombinant erythropoietin + 13-cis-retinoic acid and dihydroxylated vitamin D3: independent positive impact of erythroid response on survivalElena Crisà, Cristina Foli, Roberto Passera, et al.British Journal of Haematology|November 28, 2008
Efficacy of a combination of human recombinant erythropoietin + 13-cis-retinoic acid and dihydroxylated vitamin D3 to improve moderate to severe anaemia in low/intermediate risk myelodysplastic syndromesDario Ferrero, Antonella Darbesio, Valentina Giai, et al.Biomedicines|December 30, 2025
Telomere Length Abnormality: Investigating Approaches and Correlations with Cancer, Bone Marrow Failure and Hematological MalignanciesCorrado Tarella, Dario Ferrero, Maria Beatriz Herrera Sanchez, et al.Cancer Biology & Therapy|March 10, 2009
Increase of telomerase activity and hTERT expression in myelodysplastic syndromesFederica Briatore, Giuseppina Barrera, Stefania Pizzimenti, et al.Journal of Hematology & Oncology|January 15, 2017
Can pegylated interferon improve the outcome of polycythemia vera patients?Elena Crisà, Marco Cerrano, Eloise Beggiato, et al.Journal of Hematology & Oncology|August 10, 2016
Ruxolitinib in steroid refractory graft-vs.-host disease: a case reportEnrico Maffini, Luisa Giaccone, Moreno Festuccia, et al.Pageof 5